Who is angine de poitrine
Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.
Last updated: April 8, 2026
Key Facts
- First described by William Heberden in 1768
- Affects approximately 9.8 million Americans annually
- Coronary artery disease causes about 365,000 US deaths yearly
- Stable angina has 1-2% annual risk of heart attack
- Unstable angina requires immediate medical attention
Overview
Angine de poitrine, known in English as angina pectoris, represents a critical cardiovascular condition characterized by chest pain or discomfort resulting from reduced blood flow to the heart muscle. The term originates from French, literally translating to "chest angina," and has been recognized in medical literature for centuries. This condition serves as a warning sign of underlying coronary artery disease, where plaque buildup narrows the arteries supplying blood to the heart.
The historical understanding of angina dates back to 1768 when British physician William Heberden first provided a detailed clinical description during a lecture at the Royal College of Physicians. Heberden's observations distinguished angina from other chest conditions, noting its characteristic pattern of pain triggered by exertion and relieved by rest. His work established the foundation for modern cardiology's understanding of ischemic heart disease.
Contemporary medical practice recognizes angina as affecting approximately 9.8 million Americans annually, with significant global prevalence. The condition manifests differently across populations, with higher incidence rates in developed nations due to lifestyle factors. Understanding angina's mechanisms and presentations remains crucial for cardiovascular disease prevention and management worldwide.
How It Works
Angina develops when the heart muscle doesn't receive enough oxygen-rich blood, typically during physical exertion or emotional stress.
- Coronary Artery Narrowing: Atherosclerotic plaque buildup reduces arterial diameter by 70% or more, limiting blood flow during increased cardiac demand. This process develops over decades, with fatty deposits accumulating in artery walls.
- Myocardial Ischemia: Reduced blood flow creates oxygen deprivation in heart tissue, triggering pain signals through nerve pathways. This typically occurs when arteries are 50-70% blocked, depending on individual factors.
- Pain Mechanism: Chemical mediators like adenosine stimulate cardiac nerve endings, producing characteristic chest discomfort that may radiate to arms, neck, or jaw. The pain typically lasts 1-5 minutes with proper management.
- Trigger Factors: Physical exertion increases heart rate by 20-30 beats per minute above resting levels, while emotional stress elevates blood pressure by 10-20 mmHg, both demanding more oxygen than compromised arteries can deliver.
The imbalance between oxygen supply and demand creates temporary ischemia without permanent heart damage in stable cases. However, prolonged or severe episodes can progress to myocardial infarction if blood flow isn't restored within 20-30 minutes of symptom onset.
Types / Categories / Comparisons
Medical professionals classify angina into several distinct categories based on presentation patterns and underlying mechanisms.
| Feature | Stable Angina | Unstable Angina | Variant (Prinzmetal) Angina |
|---|---|---|---|
| Pattern | Predictable with exertion | Unpredictable, occurs at rest | Cyclical, often at night |
| Duration | 2-5 minutes typically | 10+ minutes possible | 5-15 minutes typically |
| Relief | Rest or nitroglycerin | May not respond to rest | Often responds to medication |
| Risk Level | 1-2% annual heart attack risk | High risk, medical emergency | Variable, can cause arrhythmias |
| Mechanism | Fixed plaque narrowing | Plaque rupture with clot | Coronary artery spasm |
Stable angina represents the most common form, affecting approximately 70% of angina patients, while unstable angina accounts for about 20% of cases and requires immediate intervention. Variant angina comprises the remaining 10% and involves coronary artery spasms rather than fixed blockages. Microvascular angina, affecting small heart arteries, represents another category not shown in the table but important for complete understanding.
Real-World Applications / Examples
- Clinical Diagnosis: Physicians use stress testing with 85% maximum predicted heart rate to reproduce symptoms, combined with imaging techniques showing blood flow reduction of 50% or more in affected areas. Electrocardiograms during episodes typically show ST-segment depression of 1mm or greater.
- Treatment Protocols: Standard management includes nitroglycerin providing relief within 1-3 minutes, beta-blockers reducing heart rate by 20-25%, and statins lowering LDL cholesterol by 30-50%. Approximately 60% of patients require multiple medications for adequate control.
- Interventional Procedures: Angioplasty with stent placement successfully opens blocked arteries in 95% of cases, while coronary artery bypass grafting uses 1-4 grafts to restore blood flow, with 85-90% of patients experiencing significant symptom improvement.
These approaches demonstrate modern medicine's multifaceted strategy against angina, combining pharmacological management with procedural interventions when necessary. Lifestyle modifications including smoking cessation reduce cardiovascular events by 36%, while regular exercise programs decrease angina frequency by 40-50% in compliant patients.
Why It Matters
Angina serves as a critical early warning system for coronary artery disease, allowing intervention before irreversible damage occurs. Each year, approximately 500,000 new angina cases are diagnosed in the United States alone, representing substantial healthcare costs and personal suffering. Early recognition and management can prevent progression to myocardial infarction, which claims a life every 40 seconds in America.
The economic impact is substantial, with cardiovascular diseases costing the U.S. healthcare system approximately $363 billion annually in direct and indirect expenses. Angina management represents a significant portion of these costs, particularly as populations age and risk factors like obesity and diabetes increase globally.
Future developments focus on personalized medicine approaches, with genetic testing identifying high-risk individuals and targeted therapies addressing specific pathological mechanisms. Research continues into improved diagnostic techniques and more effective treatments, aiming to reduce angina's global burden through prevention and advanced management strategies.
More Who Is in Daily Life
Also in Daily Life
More "Who Is" Questions
Trending on WhatAnswers
Browse by Topic
Browse by Question Type
Sources
- Wikipedia - Angina PectorisCC-BY-SA-4.0
Missing an answer?
Suggest a question and we'll generate an answer for it.